Beyond Air Announces Positive Preclinical Data Supporting High Concentration Nitric Oxide as a Potential Treatment for Solid Tumors

Go back to Beyond Air Announces Positive Preclinical Data Supporting High Concentration Nitric Oxide as a Potential Treatment for Solid Tumors
(NASDAQ: XAIR) Delayed: 3.11 +0.03 (0.97%)
Previous Close $3.08    52 Week High
Open $3.07    52 Week Low
Day High $3.26    P/E N/A 
Day Low $3.07    EPS
Volume 15,279